TENAX THERAPEUTICS, INC. Cost of Goods Sold (Deprecated 2018-01-31)
TENAX THERAPEUTICS, INC. (TENX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2017-03-16
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-04-30 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2015-01-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-10-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-07-31 was $0.00, a 100.00% decline year-over-year.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $0.00.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $129.80K, a 201.08% increase from fiscal 2013.
- TENAX THERAPEUTICS, INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $43.11K, a 15.89% decline from fiscal 2012.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 8 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 530 month | Cost of Goods Sold (Deprecated 2018-01-31) 533 month | Cost of Goods Sold (Deprecated 2018-01-31) 536 month | Cost of Goods Sold (Deprecated 2018-01-31) 539 month | Cost of Goods Sold (Deprecated 2018-01-31) 542 month | Cost of Goods Sold (Deprecated 2018-01-31) 545 month | Cost of Goods Sold (Deprecated 2018-01-31) 554 month | Cost of Goods Sold (Deprecated 2018-01-31) 557 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||
| 2015-12-31 | $0.00 10-K · filed 2017-03-16 | ||||||||||||
| 2015-04-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | $0.00 10-K · filed 2017-03-16 | |||||||||
| 2015-01-31 | $0.00 10-Q · filed 2015-03-17 | $0.00 derived: sum of 2 quarters · filed 2015-03-17 | $0.00 10-Q · filed 2015-03-17 | $98.53K derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-10-31 | $0.00 10-Q · filed 2014-12-15 | $0.00 10-Q · filed 2014-12-15 | $98.53K derived: sum of 3 quarters · filed 2017-03-16 | $98.94K derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-07-31 | $0.00 10-Q · filed 2014-09-15 | $98.53K derived: sum of 2 quarters · filed 2017-03-16 | $98.94K derived: sum of 3 quarters · filed 2017-03-16 | $102.29K derived: sum of 4 quarters · filed 2017-03-16 | |||||||||
| 2014-04-30 | $98.53K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $98.94K derived: sum of 2 quarters · filed 2017-03-16 | $102.29K derived: sum of 3 quarters · filed 2017-03-16 | $129.80K 10-K · filed 2017-03-16 | |||||||||
| 2014-01-31 | $410.00 10-Q · filed 2015-03-17 | $3.77K derived: sum of 2 quarters · filed 2015-03-17 | $31.27K 10-Q · filed 2015-03-17 | $57.81K derived: sum of 4 quarters · filed 2016-03-14 | $383.85K 10-Q · filed 2014-03-17 | ||||||||
| 2013-10-31 | $3.35K 10-Q · filed 2014-12-15 | $30.86K 10-Q · filed 2014-12-15 | $57.40K derived: sum of 3 quarters · filed 2016-03-14 | $58.93K derived: sum of 4 quarters · filed 2016-03-14 | $383.44K 10-Q · filed 2013-12-17 | ||||||||
| 2013-07-31 | $27.51K 10-Q · filed 2014-09-15 | $54.04K derived: sum of 2 quarters · filed 2016-03-14 | $55.58K derived: sum of 3 quarters · filed 2016-03-14 | $64.71K derived: sum of 4 quarters · filed 2016-03-14 | $380.09K 10-Q · filed 2013-09-17 | ||||||||
| 2013-04-30 | $26.53K derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | $28.07K derived: sum of 2 quarters · filed 2016-03-14 | $37.20K derived: sum of 3 quarters · filed 2016-03-14 | $43.11K 10-KT · filed 2016-03-14 | $352.58K 10-K · filed 2013-06-26 | ||||||||
| 2013-01-31 | $1.53K 10-Q · filed 2014-03-17 | $10.67K derived: sum of 2 quarters · filed 2014-03-17 | $16.58K 10-Q · filed 2014-03-17 | $20.22K derived: sum of 4 quarters · filed 2014-03-17 | $326.05K 10-Q · filed 2013-03-18 | ||||||||
| 2012-10-31 | $9.13K 10-Q · filed 2013-12-17 | $15.04K 10-Q · filed 2013-12-17 | $18.68K derived: sum of 3 quarters · filed 2013-12-17 | $21.19K derived: sum of 4 quarters · filed 2013-12-17 | $324.51K 10-Q · filed 2012-12-14 | ||||||||
| 2012-07-31 | $5.91K 10-Q · filed 2013-09-17 | $9.55K derived: sum of 2 quarters · filed 2013-09-17 | $12.06K derived: sum of 3 quarters · filed 2013-09-17 | $22.56K derived: sum of 4 quarters · filed 2013-09-17 | $315.38K 10-Q · filed 2012-09-19 | ||||||||
| 2012-04-30 | $3.64K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-26 | $6.15K derived: sum of 2 quarters · filed 2013-06-26 | $16.65K derived: sum of 3 quarters · filed 2013-06-26 | $51.25K 10-K · filed 2013-06-26 | $309.47K 10-K · filed 2012-07-25 | ||||||||
| 2012-01-31 | $2.51K 10-Q · filed 2013-03-18 | $13.01K derived: sum of 2 quarters · filed 2013-03-18 | $47.62K 10-Q · filed 2013-03-18 | $230.08K derived: sum of 4 quarters · filed 2013-03-18 | $305.83K 10-Q · filed 2012-03-15 | ||||||||
| 2011-10-31 | $10.50K 10-Q · filed 2012-12-14 | $45.10K 10-Q · filed 2012-12-14 | $227.57K derived: sum of 3 quarters · filed 2012-12-14 | $253.54K derived: sum of 4 quarters · filed 2012-12-14 | $303.32K 10-Q · filed 2011-12-15 | ||||||||
| 2011-07-31 | $34.60K 10-Q · filed 2012-09-19 | $217.07K derived: sum of 2 quarters · filed 2012-09-19 | $243.04K derived: sum of 3 quarters · filed 2012-09-19 | $252.00K derived: sum of 4 quarters · filed 2012-09-19 | $292.82K 10-Q · filed 2011-09-19 | ||||||||
| 2011-04-30 | $182.46K derived: 10-K 12 month − 10-Q 9 month · filed 2012-07-25 | $208.44K derived: sum of 2 quarters · filed 2012-07-25 | $217.39K derived: sum of 3 quarters · filed 2012-07-25 | $219.18K 10-K · filed 2012-07-25 | |||||||||
| 2011-01-31 | $25.97K 10-Q · filed 2012-03-15 | $34.93K derived: sum of 2 quarters · filed 2012-03-15 | $36.72K 10-Q · filed 2012-03-15 | ||||||||||
| 2010-10-31 | $8.96K 10-Q · filed 2011-12-15 | $10.74K 10-Q · filed 2011-12-15 | |||||||||||
| 2010-07-31 | $1.79K 10-Q · filed 2011-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |